 Vamsi Guntur
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 8 | 2025 | 2295 | 0.900 |
Why?
| | Granulomatosis with Polyangiitis | 2 | 2021 | 44 | 0.710 |
Why?
| | Churg-Strauss Syndrome | 1 | 2020 | 26 | 0.670 |
Why?
| | Nicotinic Agonists | 1 | 2014 | 129 | 0.390 |
Why?
| | Airway Resistance | 2 | 2013 | 41 | 0.370 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2012 | 434 | 0.370 |
Why?
| | Airway Remodeling | 1 | 2012 | 64 | 0.360 |
Why?
| | Nicotine | 1 | 2014 | 334 | 0.360 |
Why?
| | Expectorants | 1 | 2010 | 24 | 0.350 |
Why?
| | Drug Delivery Systems | 2 | 2010 | 365 | 0.340 |
Why?
| | Nebulizers and Vaporizers | 3 | 2013 | 86 | 0.330 |
Why?
| | Acetylcysteine | 1 | 2010 | 145 | 0.320 |
Why?
| | Smoking Cessation | 1 | 2014 | 442 | 0.320 |
Why?
| | Protein Kinase Inhibitors | 2 | 2012 | 916 | 0.300 |
Why?
| | Respiratory Therapy | 1 | 2007 | 23 | 0.270 |
Why?
| | Smoking | 1 | 2014 | 1627 | 0.250 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2010 | 528 | 0.250 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2010 | 801 | 0.230 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2021 | 804 | 0.230 |
Why?
| | Antacids | 1 | 2024 | 16 | 0.230 |
Why?
| | Laryngopharyngeal Reflux | 1 | 2024 | 15 | 0.230 |
Why?
| | Allergens | 3 | 2025 | 409 | 0.220 |
Why?
| | Respiration, Artificial | 1 | 2008 | 645 | 0.210 |
Why?
| | Anti-Asthmatic Agents | 2 | 2021 | 395 | 0.200 |
Why?
| | Lymphocytes | 1 | 2025 | 397 | 0.200 |
Why?
| | Mucociliary Clearance | 1 | 2022 | 45 | 0.180 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1081 | 0.180 |
Why?
| | Interleukin-5 | 1 | 2021 | 44 | 0.170 |
Why?
| | Bronchoscopy | 1 | 2022 | 223 | 0.170 |
Why?
| | Fever | 1 | 2022 | 306 | 0.170 |
Why?
| | Eosinophilia | 2 | 2021 | 218 | 0.170 |
Why?
| | Aerosols | 3 | 2010 | 176 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2025 | 1242 | 0.160 |
Why?
| | Steroids | 1 | 2020 | 167 | 0.160 |
Why?
| | Neutrophils | 1 | 2025 | 1238 | 0.160 |
Why?
| | Pilot Projects | 2 | 2024 | 1710 | 0.150 |
Why?
| | Antineoplastic Agents | 1 | 2010 | 2129 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2025 | 1164 | 0.150 |
Why?
| | Lung | 3 | 2022 | 4060 | 0.150 |
Why?
| | DNA | 1 | 2025 | 1459 | 0.140 |
Why?
| | Humans | 13 | 2025 | 137585 | 0.140 |
Why?
| | Macrophages | 1 | 2025 | 1547 | 0.140 |
Why?
| | Lung Neoplasms | 1 | 2010 | 2526 | 0.130 |
Why?
| | Cats | 3 | 2013 | 210 | 0.130 |
Why?
| | Signal Transduction | 2 | 2025 | 5079 | 0.130 |
Why?
| | Insulin | 1 | 2007 | 2409 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 786 | 0.130 |
Why?
| | Equipment and Supplies | 1 | 2014 | 42 | 0.110 |
Why?
| | Cat Diseases | 1 | 2013 | 21 | 0.100 |
Why?
| | Lidocaine | 1 | 2013 | 42 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2007 | 2531 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2013 | 80 | 0.100 |
Why?
| | Inflammation | 2 | 2022 | 2837 | 0.100 |
Why?
| | Cisplatin | 2 | 2010 | 320 | 0.090 |
Why?
| | Perception | 1 | 2014 | 359 | 0.090 |
Why?
| | Bronchoconstriction | 1 | 2010 | 32 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2007 | 3715 | 0.080 |
Why?
| | Biomarkers | 1 | 2022 | 4149 | 0.080 |
Why?
| | Male | 8 | 2025 | 67762 | 0.080 |
Why?
| | Paclitaxel | 1 | 2010 | 230 | 0.080 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 257 | 0.070 |
Why?
| | Prospective Studies | 1 | 2020 | 7604 | 0.070 |
Why?
| | Transfection | 1 | 2010 | 945 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 852 | 0.070 |
Why?
| | Blotting, Western | 1 | 2010 | 1226 | 0.070 |
Why?
| | Adult | 4 | 2024 | 37929 | 0.070 |
Why?
| | Cell Survival | 1 | 2010 | 1120 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2024 | 10811 | 0.070 |
Why?
| | Antioxidants | 1 | 2010 | 584 | 0.070 |
Why?
| | Alternaria | 1 | 2025 | 13 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2022 | 15657 | 0.050 |
Why?
| | Cynodon | 2 | 2013 | 2 | 0.050 |
Why?
| | Methacholine Chloride | 2 | 2013 | 52 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3412 | 0.050 |
Why?
| | Female | 6 | 2025 | 73304 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1692 | 0.050 |
Why?
| | Animals | 5 | 2025 | 36940 | 0.050 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 140 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2010 | 4295 | 0.040 |
Why?
| | Prednisone | 1 | 2021 | 240 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2025 | 3015 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 565 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2071 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2734 | 0.030 |
Why?
| | Bronchoconstrictor Agents | 1 | 2013 | 16 | 0.030 |
Why?
| | Thiazoles | 1 | 2012 | 123 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 216 | 0.020 |
Why?
| | Middle Aged | 2 | 2024 | 33479 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2013 | 564 | 0.020 |
Why?
| | Piperidines | 1 | 2012 | 206 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2012 | 342 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2010 | 332 | 0.020 |
Why?
| | Catheterization | 1 | 2010 | 179 | 0.020 |
Why?
| | United States | 1 | 2007 | 14841 | 0.020 |
Why?
| | Deoxycytidine | 1 | 2010 | 179 | 0.020 |
Why?
| | Dogs | 1 | 2010 | 413 | 0.020 |
Why?
| | Eosinophils | 1 | 2012 | 332 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 652 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2010 | 688 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6763 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 506 | 0.020 |
Why?
| | Radiography | 1 | 2010 | 822 | 0.020 |
Why?
| | Mice | 1 | 2025 | 17787 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2057 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1793 | 0.020 |
Why?
| | Child | 1 | 2021 | 21935 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6828 | 0.010 |
Why?
|
|
Guntur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|